Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07511244Recruiting
Spinal cord stimulation for bladder and bowel control after spinal cord injury
This trial tests whether spinal cord stimulation can help improve bladder and bowel function in people who have had a spinal cord injury for more than 6 months. The goal is to see if this treatment can restore more control and quality of life.
BeijingAges 18–60 - NCT07512830Recruiting
Using Hypnosis to Help During Heart Ultrasound
This study tests whether hypnosis (guided relaxation) can help patients feel more comfortable and less anxious during a heart ultrasound procedure that looks at the heart from inside the throat. The goal is to see if it reduces discomfort and the need for sedating medications.
Paris, Île-de-France RegionAges 18 years+ - NCT07514780RecruitingPhase 1
Safety study of JW0061 in healthy adults
This is an early-stage safety test of a new drug called JW0061 in people without serious health conditions. Researchers will monitor how your body processes the drug and any side effects that occur.
Seoul, SeoulAges 19–55 - NCT07515599Recruiting
Study of blood pressure medicine for nighttime control
This study watches how well Olmetec (a blood pressure medicine) controls your blood pressure, especially at night. Researchers will use a special monitor you wear for 24 hours to measure your blood pressure patterns and see if the medicine is working.
SeoulAges 19 years+ - NCT07517172Recruiting
Brain Stimulation Patch for Jaw Pain: Home Treatment Study
This study tests whether a small, stick-on electrical patch placed on your ear can reduce temporomandibular disorder (TMD) jaw pain when used at home. You would apply the patch yourself and complete surveys about your pain to help researchers learn if this non-invasive approach is safe and feasible.
Minneapolis, MinnesotaAges 18–65 - NCT07517393Recruiting
Creating a Digital Lung Model Using AI and CT Scans
This study collects information from your chest CT scans and medical history to build an artificial intelligence model of how your lungs work. This 'digital twin' may help doctors better understand and predict lung health in the future.
Peschiera del Garda, VeronaAges 18 years+ - NCT07519330RecruitingPhase 2
Testing HH-006 treatment for chronic hepatitis B
This study tests a new drug called HH-006 to see if it can help treat chronic hepatitis B infection. Participants will be grouped by their infection level, and the study checks whether the drug is safe and works to reduce the hepatitis B virus.
Chongqing, Chongqing MunicipalityAges 18–45 - NCT07519564RecruitingPhase 1
Study of GB18 Injection for Cancer-Related Weight Loss
This Phase 1 trial tests a new drug called GB18 to help cancer patients who have experienced significant weight loss and muscle wasting—a condition called cancer cachexia. The drug works by targeting a specific protein involved in weight loss, and researchers want to learn if it can help patients regain weight and strength while also being safe.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07520838Recruiting
Telehealth support for autism evaluation and caregiver coaching
This study tests whether telehealth (video visits) can help families get faster access to autism evaluation and support. A coach will work with you and your child over 12 weeks to help navigate care and teach strategies at home.
Minneapolis, MinnesotaAges 1 year+ - NCT07521345RecruitingPhase 1
Safety Study of HSK55879 Tablet in Healthy Adults
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
Hefei, AnhuiAges 18–45 - NCT07522970RecruitingPhase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT07524114Recruiting
Tracking cancer recurrence risk after treatment
This study uses advanced blood tests to detect tiny amounts of cancer DNA after you've completed cancer treatment. The goal is to catch any signs of cancer coming back as early as possible, which may help doctors intervene sooner.
Toronto, OntarioAges 18 years+ - NCT07524231Recruiting
Laughter Yoga Effects on Health and Well-being
This study tests whether laughter yoga—guided exercises that combine laughter with breathing—can improve health outcomes. Researchers will measure how it affects participants' physical and mental well-being over time.
ElâzığAges 18 years+ - NCT07525869Recruiting
Pegfilgrastim to prevent low white blood cells in triple-negative breast cancer
This study tests whether a medicine called pegfilgrastim can help prevent dangerously low white blood cell counts in women with triple-negative breast cancer receiving a specific chemotherapy combination. Low white blood cells increase infection risk, so this medicine may help patients stay safer during treatment.
Seoul, Seodaemun-guAges 19–70 - NCT07526142Recruiting
Circles of Safety Training for Youth Sports Leaders
This study evaluates a safety program called Circles of Safety designed for coaches and youth sports leaders. The research aims to understand how this training helps protect young athletes from harm.
Gainesville, FloridaAges 18 years+ - NCT07526259Recruiting
Novel gum recession surgery compared to standard technique
This study compares two surgical approaches to treat multiple areas of receded gums (where gum tissue has pulled back from teeth). Both techniques use grafted tissue to restore gum coverage and protect tooth roots.
Cairo, AlManialAges 18 years+ - NCT07527624Recruiting
Study of work and social inclusion for young adults with rare genetic conditions
This study looks at how young adults aged 15–25 with rare genetic conditions (like certain bone, skin, hearing, or facial conditions) are doing in school, work, and social life. Researchers want to understand what helps or prevents young people with these conditions from being included in their communities.
Paris, Île-de-France RegionAges 15–25 - NCT07528495RecruitingPhase 2/Phase 3
Skipping neck radiation for oral cancer after surgery
This trial tests whether patients with early-stage oral cancer who have surgery and lymph-node removal can skip radiation to the neck if certain favorable conditions are met. The goal is to reduce side effects like difficulty swallowing while keeping cancer control strong.
Jhajjar, HaryanaAges 18–70 - NCT07529288Recruiting
Traditional medicine approaches for male infertility
This study explores how traditional medicine may help treat a specific type of male infertility where sperm count is low, movement is poor, and shape is abnormal. Researchers will evaluate whether traditional medicine approaches can improve these sperm problems.
Ho Chi Minh City, Ho Chi Minh CityAges 18–60 - NCT07529444Recruiting
Testing ways to clean dental implants affected by infection
This study tests different methods to clean and treat dental implants that have developed an infection around them (peri-implantitis). The goal is to find the best way to remove harmful bacteria and save your implant.
ZagrebAges Any age - NCT07529717RecruitingPhase 1/Phase 2
Early-stage study of AZD8359 for advanced prostate cancer
This study tests a new experimental drug (AZD8359) designed to target prostate cancer cells in men whose cancer has progressed despite previous treatments. The drug works by directing immune cells to attack cancer cells.
Orlando, FloridaAges 18–100 - NCT07532486Recruiting
Guselkumab dosing study for moderate-to-severe psoriasis
This study tests whether a higher dose of guselkumab (a biologic medicine) given less frequently works as well as the standard dose for treating moderate-to-severe plaque psoriasis. The goal is to find a dosing schedule that is both effective and convenient for patients.
Hangzhou, ZhejiangAges 18 years+ - NCT07532590Recruiting
Pancreas Plus: smartphone app for pancreatic cancer monitoring
This study tests a smartphone app designed to help people with pancreatic cancer track their health and receive educational information about their condition. The app asks simple questions regularly and provides supportive content to help you stay informed and connected to your care team.
Pavia, PaviaAges 18 years+ - NCT07534176RecruitingPhase 1
How Smoking Affects a New Drug in Postmenopausal Women
This study tests how a new experimental drug (GS1-144) moves through the body differently in women who smoke versus those who don't. Researchers want to understand if smoking changes how the drug works, which could help doctors prescribe the right dose.
Shandong, JinanAges 40–65
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.